First Response: NSCLC Highlights From Chicago

1
First Response NSCLC Highlights From Chicago
2
(No Transcript)
3
RTOG 0617 Overall Survival Results
4
ALK Rearrangement Positive Advanced NSCLC
5
MPDL3280A Phase Ia Response by PD-L1 IHC Status
6
GALAXY-1 Overall Survival Adenocarcinoma
7
LUME Lung 1 Overall Survival Adenocarcinoma
8
PROSE Trial VeriStrat Classification
9
DELTA Trial Outcome Unselected
10
Maintenance Therapy
11
Abbreviations
12
Abbreviations (cont)
13
References
14
References (cont)
15
References (cont)
16
References (cont)
17
References (cont)
18
References (cont)